Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Media Filtration Before Use – V 2.0

Posted on By


Biosimilars: SOP for Media Filtration Before Use – V 2.0


Standard Operating Procedure for Media Filtration Before Use in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/128/2025
Supersedes SOP/BS/128/2022
Page No. Page 1 of 11
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for sterile filtration of culture media used in upstream biosimilar processes to ensure removal of particulates and microbial contaminants prior to inoculation or cell culture applications.

2. Scope

This SOP applies to the filtration of liquid media, feeds, and supplements prepared in the media preparation area and used in biosimilar manufacturing, including cell line development and bioreactor inoculation.

3. Responsibilities

  • Production: Perform filtration as per batch requirement and document process.
  • Engineering: Ensure filters and filtration setups are installed and functioning properly.
  • QA: Verify filter integrity test and review batch records.

4. Accountability

The Head of Manufacturing is accountable for ensuring that only sterile, filtered media is used in any cell culture-related process steps and that all filtration steps are documented and verified.

5. Procedure

5.1 Preparation for Filtration

  1. Verify that the media preparation is complete, pH adjusted, and labeled properly.
  2. Transfer media into a sterile container under a biosafety cabinet (Grade A/ISO 5).
  3. Ensure use of 0.22 µm sterilizing-grade membrane filters with valid certificate of compliance.
  4. Record filter lot number and expiry in Annexure-1.

5.2 Filtration Setup

  1. Assemble filtration setup using:
    • Peristaltic pump (if applicable)
    • Pre-sanitized tubing sets
    • Sterile storage carboy or bioreactor input
  2. Perform pre-use filter integrity check (Bubble Point Test or Diffusion Test).
  3. Document test result in Annexure-2: Filter Integrity Record.

5.3 Execution of Filtration

  1. Connect inlet tubing to media container and outlet to receiving sterile container or line.
  2. Start pump or use gravity feed ensuring flowrate as per validation (typically 0.5–2.0 L/min).
  3. Maintain aseptic technique throughout the process.
  4. Monitor for pressure build-up or leakage.
  5. Upon completion, perform post-use filter integrity test.

5.4 Labeling and Documentation

  1. Label filtered media with:
    • “Sterile Filtered” status
    • Date and Time
    • Used by
    • Batch No.
  2. Record details in Annexure-3: Media Filtration Log.
  3. Submit completed records to QA for review.

6. Abbreviations

  • µm: Micrometer
  • QA: Quality Assurance
  • GMP: Good Manufacturing Practice

7. Documents

  1. Filter Certificate of Compliance – Annexure-1
  2. Filter Integrity Test Record – Annexure-2
  3. Media Filtration Log – Annexure-3

8. References

  • USP <797> – Sterile Preparations
  • WHO TRS 1019 – GMP for Biotech
  • ISPE Baseline Guide – Sterile Manufacturing

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: Filter Certificate Record

Date Filter Type Lot No. Expiry Verified By
04/05/2025 0.22 µm PES FTR-2201 12/2026 Ajay Verma

Annexure-2: Filter Integrity Test Record

Date Test Type Result Status Checked By
04/05/2025 Bubble Point Passed Accepted Sunita Reddy

Annexure-3: Media Filtration Log

Date Media Volume Filtered By Integrity Status Remarks
04/05/2025 CHO Feed A 15L Ajay Verma Pass Clear

Revision History:

Revision Date Revision No. Revision Details Reason for Revision Approved By
04/05/2025 2.0 Clarified integrity test and labeling Audit Observation
See also  Biosimilars: SOP for Cleaning and Sanitization of Bioreactors - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Sterile Injectable Manufacturing: SOP for Cross-Verification of In-Process Data – V 2.0
Next Post: Analytical Method Development: SOP for Capillary Electrophoresis Method Development – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version